CDH2 and hepatocellular carcinoma: POVPC decreased the expression levels of epithelial marker E-cadherin, whereas it increased the mesenchymal marker N-cadherin in human hepatocellular carcinoma cells (HepG2) in dose- and time-dependent ways as determined by immunoblotting analysis (Figure 1A,B and Figure S1A,B).